Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Por um escritor misterioso
Descrição
![Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//21735743/0000001900000002/v1_202302031212/S2173574323000084/v1_202302031212/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9184xd8ym1IgxXJ6I4p31f1upH6Ra9/FExf9t4wRA9EIdwyxQA4qVT5I6a0jw4uY4u8XmU7h6mX3W0UPNCWDHo2+SOfFjUk7Klik3EDkhaB6wcjePV0iT5rMfH+DmxSH68fFAo5MQOfDAj92dygGzW8bQExtm89GAphEoYcgAs5rBqEtW0NyB9f+XJXy/RBw/UoAkvaseHXOo9vGKqfrSpjGR7XoO2M/W2k8falvgVwQ+KoJTMQKTG54GfmbyMvQKkimog2bQRHhoA1ZN/NaqSk=)
Disease control in patients with ankylosing spondylitis in real
![Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor](https://www.researchgate.net/publication/261999594/figure/fig1/AS:1088906774753280@1636627014223/Changes-in-disease-activity-after-12-weeks-of-anti-TNF-a-therapy-Disease-activity-scores_Q320.jpg)
Changes in disease activity after 12 weeks of anti-TNF-α therapy
![Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs42358-021-00219-y/MediaObjects/42358_2021_219_Fig1_HTML.png)
Brazilian Society of Rheumatology 2020 guidelines for psoriatic
![Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs42358-022-00270-3/MediaObjects/42358_2022_270_Fig2_HTML.png)
Maintained activity in ankylosing spondylitis patients treated
![Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor](https://ars.els-cdn.com/content/image/1-s2.0-S0049017222001329-gr1.jpg)
Predictors of ASDAS-CRP inactive disease in axial
![Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor](https://www.jrheum.org/content/jrheum/49/10/1100/F3.large.jpg)
Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS
![Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor](https://ard.bmj.com/content/annrheumdis/82/1/19/F2.large.jpg)
ASAS-EULAR recommendations for the management of axial
Ankylosing spondylitis disease activity score is related to NSAID
![Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor](https://journals.sagepub.com/cms/10.1177/1759720X231189005/asset/images/large/10.1177_1759720x231189005-fig5.jpeg)
The effect of ixekizumab on axial manifestations in patients with
de
por adulto (o preço varia de acordo com o tamanho do grupo)
